健脾补肾方加味调节调节性T淋巴细胞/辅助性T淋巴细胞平衡的抗肝纤维化作用机制

潘凯; 赵强; 陶艳艳; 陈高峰; 刘成海

doi:10.3969/j.issn.1001-5256.2016.08.017

健脾补肾方加味调节调节性T淋巴细胞/辅助性T淋巴细胞平衡的抗肝纤维化作用机制

DOI: 10.3969/j.issn.1001-5256.2016.08.017

1. 上海中医药大学附属曙光医院肝病研究所
2. 上海高校中医内科学E-研究院
3. 上海市中医临床重点实验室

基金项目:

上海市医学领军人才计划(LJ10005)；

详细信息

中图分类号: R259
计量
- 文章访问数: 231
- HTML全文浏览量: 11
- PDF下载量: 130
- 被引次数: 0
出版历程
- 收稿日期: 2016-04-23
- 出版日期: 2016-08-20

Efficacy of Jiawei Jianpi Bushen prescription in treatment of liver fibrosis and its role in regulating Treg/Th17 balance

Institute of Liver Diseases,Shuguang Hospital,Shanghai University of Traditional Chinese Medicine

Research funding:

摘要

摘要: 目的观察健脾补肾方加味对大鼠肝纤维化的治疗效果及对调节性T淋巴细胞（Treg）和辅助性T淋巴细胞（Th）17的影响。方法 32只雄性Wistar大鼠随机分为正常组、模型组、健脾补肾方组和健脾补肾方加味组,四氯化碳溶液皮下注射造模。用药组在第4周开始分别给予健脾补肾方和健脾补肾方加味,第8周末处死。测定大鼠血清肝功能,观察肝组织炎症及纤维化情况、Foxp3和白细胞介素（IL）17蛋白与基因表达及血清IL-4和IL-17表达情况。计量资料多组间比较采用方差分析,进一步两两比较采用LSD-t检验,等级资料比较采用Ridit检验。结果与正常组相比,模型组大鼠血清总胆汁酸（TBA）、ALP、TBil、ALT和AST均明显升高（P值均<0.05）,肝脏胶原沉积明显、α平滑肌肌动蛋白（αSMA）表达增多（P值均<0.05）。与模型组相比,健脾补肾组血清ALP、TBA、TBil和ALT均明显降低（P值均<0.05）;健脾补肾方加味组血清ALP、TBA、TBil、ALT和AST均明显降低（P值均<0.05）;各用药组肝脏胶原沉积和αSMA表达明显减少（P值均<0.05）。与...
- 肝硬化,实验性 /
- 中药疗法 /
- 健脾 /
- 补肾
Abstract: Objective To investigate the therapeutic effect of Jiawei Jianpi Bushen prescription in liver fibrosis in rats and its effect on regulatory T( Treg) cells and T helper 17( Th17) cells. Methods A total of 32 male Wistar rats were randomly divided into normal group,model group,Jianpi Bushen prescription group,and Jiawei Jianpi Bushen prescription group. The model was established by subcutaneous injection of CCl4. The administration groups were given Jianpi Bushen decoction and Jiawei Jianpi Bushen decoction since week 4 and sacrificed at the end of week 8. The serum markers of liver function were measured,the status of liver inflammation and fibrosis was observed,and the protein and mRNA expression of Fox3 and interleukin- 17( IL- 17) and serum levels of interleukin- 4( IL- 4) and IL- 17 were also observed. An analysis of variance was used for comparison of continueus data between multiple groups,the LSD t- test was used for comparison of countinuous data between two groups; the Ridit test was used for comparison of ranked data. Results Compared with the normal group,the model group showed significant increases in total bile acid( TBA),alkaline phosphatase( ALP),total bilirubin( TBil),alanine aminotransferase( ALT),and aspartate aminotransferase( AST)( all P < 0. 05),as well as significant collagen deposition in the liver and significantly increased expression of α- smooth muscle actin( α- SMA)( both P < 0. 05). Compared with the model group,the Jianpi Bushen decoction group showed significant reductions in serum ALP,TBA,TBil,and ALT( all P < 0. 05); the Jiawei Jianpi Bushen decoction group showed significant reductions in serum ALP,TBA,TBil,ALT,and AST( all P < 0. 05); the administration groups showed significant reductions in collagen deposition in the liver and expression of α- SMA( all P < 0. 05). Compared with the Jianpi Bushen decoction group,the Jiawei Jianpi Bushen decoction group had significantly reduced TBA,ALT,and AST( all P < 0. 05). Compared with the normal group,the model group showed significant increases in the protein and mRNA expression of IL- 17 in the liver tissue and a significant increase in the mRNA expression ratio of IL- 17 to Foxp3( all P < 0. 05),a significant increase in serum IL- 17 level,and significant reductions in serum levels of IL- 4 and IL- 17( all P < 0. 05). Compared with the model group,the administration groups showed significant reductions in the protein and mRNA expression of IL- 17 in the liver tissue and a significant reduction in the mRNA expression ratio of IL- 17 to Foxp3( all P < 0. 05),a significant reduction in serum IL- 17 level,and significant increases in serum levels of IL- 4 and IL- 17( all P <0. 05). Conclusion Jiawei Jianpi Bushen prescription has improved efficacy in the treatment of liver fibrosis,and its mechanism of action may be associated with the regulation of Treg / Th17 imbalance.
- liver cirrhosis /
- experimental /
- DRUG THERAPY(TCD) /
- strengthening spleen

HTML全文

参考文献(15)

[1] HUANG JL.Clinical efficacy of Jianpi Bushen prescription combined with ursodeoxycholic acid in treatment of primary biliary cirrhosis[D].Shanghai:Shanghai Univ Tradit Chin Med,2011.(in Chinese)黄君兰.健脾补肾方联合熊去氧胆酸治疗原发性胆汁性肝硬化的临床观察[D].上海:上海中医药大学,2011.

[2]HAN XH,CHEN JM,ZHANG L,et al.Effects of Qinggan Huoxue formula on gene expression during endoplasmic reticulum stress-induced apoptosis in rats with ethanol-induced liver injury[J].World Chin J Dig,2009,17(13):1279-1285.(in Chinese)韩向晖,陈珺明,张莉,等.清肝活血方对酒精性肝损伤大鼠内质网应激反应性凋亡基因表达的影响[J].世界华人消化杂志,2009,17(13):1279-1285.

[3]HAN XH,WANG JY,ZHENG PY,et al.Attenuation and mechanism of endoplasmic reticulum stress-mediated hepatocyte apoptosis in rats with alcohol-induced liver injury by qinggan huoxue recipe and its disassembled formulas[J].Chin J Integr Tradit West Med,2011,31(5):653-658.(in Chinese)韩向晖,王见义,郑培永,等.清肝活血方及其拆方抗酒精性肝损伤大鼠肝细胞内质网应激性凋亡的作用及机制[J].中国中西医结合杂志,2011,31(5):653-658.

[4]WANG L,DU H,LIU Y,et al.Chinese medicine bu xu hua yu recipe for the regulation of treg/th17 ratio imbalance in autoimmune hepatitis[J].Evid Based Complement Alternat Med,2015,2015:461294.

[5] ZHAO W.Comparison of anti-hepatic fibrosis effects of blood-activating and stasis-resolving analogous prescriptions and their mechanisms of action against lipid peroxidation damage[D].Shanghai:Shanghai Univ Tradit Chin Med,2012.(in Chinese)赵韦.活血化瘀类方抗肝纤维化疗效比较及其抗脂质过氧化损伤的作用机制[D].上海:上海中医药大学,2012.

[6]DONG ZH,XU HY,QI HB.Clinical observation of integrative Chinese and Western medicine in treatment of 25 cases of primary biliary cirrhosis[J].World J Integr Tradit Western Med,2009,4(3):185-188.(in Chinese)董振华,徐慧媛,齐贺彬.中西医结合治疗原发性胆汁性肝硬化25例临床观察[J].世界中西医结合杂志,2009,4(3):185-188.

[7]ZHAO SG,CHEN X,LEI KJ,et al.Effects of spleen-strengthening,kidney-tonifying,and liver-soothing therapy on lipid peroxidation and cytokines in patients with nonalcoholic fatty liver disease[J].Chin J Integr Tradit West Med Liver Dis,2013,23(5):301-302.(in Chinese)赵书刚,陈昕,雷开键,等.健脾补肾疏肝法对非酒精性脂肪性肝病患者脂质过氧化和细胞因子的影响[J].中西医结合肝病杂志,2013,23(5):301-302.

[8]YU H,BAO YJ,HU SJ,et al.The effects of jianpi bushen fang on the expression of VEGF in the of BALB/c mouse model of colorectal liver metastases[J].J Liaoning Univ Tradit Chin Med,2015,17(4):151-153.(in Chinese)于卉,包益洁,胡送娇,等.健脾补肾方对BALB/c鼠大肠癌肝转移模型中VEGF表达的影响[J].辽宁中医药大学学报,2015,17(4):151-153.

[9]ZHOU ZH,SUN XH,LI M,et al.Effect of kidney-tonifying and spleen-strengthening prescription on PD-1 and PD-L1 expression in HBeA g-positive chronic hepatitis B patients with slightly increased ALT levels[J].J Clin Hepatol,2015,31(1):58-62.(in Chinese)周振华,孙学华,李曼,等.补肾健脾方对ALT轻度升高的HBeA g阳性慢性乙型肝炎患者程序性死亡受体1/程序性死亡配体1表达的影响[J].临床肝胆病杂志,2015,31(1):58-62.

[10]ZHAO J.Clinical efficacy of regulating and supplementing liverspleen and kidney formula combiend with Western medicine for treatment of cirrhosis[J].Liaoning J Tradit Chin Med,2014,41(5):977-979.(in Chinese)赵娟.调肝健脾补肾方联合西医治疗肝硬化腹水临床观察[J].辽宁中医杂志,2014,41(5):977-979.

[11]ZHANG XL,LU LW,TANG SX,et al.“Combined equally important treatment and nursing”in prevention and treatment of HBV[J].Jilin J Tradit Chin Med,2016,36(7):656-658.(in Chinese)张向磊,卢立伟,唐世霞,等.治养并重、养治结合防治乙型病毒性肝炎[J].吉林中医药,2016,36(7):656-658.

[12]CHEN Y,FANG J,CHEN X,et al.Effects of the Treg/Th17 cell balance and their associated cytokines in patients with hepatitis B infection[J].Exp Ther Med,2015,9(2):573-578.

[13]YANG CY,MA X,TSUNEYAMA K,et al.IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis:implications for therapy[J].Hepatology,2014,59(5):1944-1953.

[14]ZHOU L,IVANOV II,SPOLSKI R,et al.IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways[J].Nat Immunol,2007,8(9):967-974.

[15]RONG G,ZHOU Y,XIONG Y,et al.Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis:the serum cytokine profile and peripheral cell population[J].Clin Exp Immunol,2009,156(2):217-225.

施引文献

资源附件(0)

访问统计